Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2020 | 33233320 | PubTator, text mining | PubMed |
| Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes-Considerations for Future Studies. | Int J Mol Sci | 2020 | 33228212 | PubTator, text mining | PubMed |
| FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer. | Front Immunol | 2020 | 33224141 | PubTator, text mining | PubMed |
| Clinical and Molecular Characterization of Fanconi Anemia Patients in Turkey. | Mol Syndromol | 2020 | 33224012 | PubTator, text mining | PubMed |
| Genetic Mutations in Young Nonsmoking Patients With Oral Cavity Cancer: A Systematic Review. | OTO Open | 2020 | 33210069 | PubTator, text mining | PubMed |
| DNA Repair Syndromes and Cancer: Insights Into Genetics and Phenotype Patterns. | Front Pediatr | 2020 | 33194896 | PubTator, text mining | PubMed |
| Genetic Predisposition to Solid Pediatric Cancers. | Front Oncol | 2020 | 33194750 | PubTator, text mining | PubMed |
| Two replication fork remodeling pathways generate nuclease substrates for distinct fork protection factors. | Sci Adv | 2020 | 33188024 | PubTator, text mining | PubMed |
| Molecular nature of breakdown of the folic acid under hydrothermal treatment: a combined experimental and DFT study. | Sci Rep | 2020 | 33184321 | PubTator, text mining | PubMed |
| Evaluation of Grewia ferruginea Hochst ex A. Rich Mucilage as Suspending Agent in Metronidazole Benzoate Suspension. | Biomed Res Int | 2020 | 33178834 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer. | Front Oncol | 2020 | 33178606 | PubTator, text mining | PubMed |
| Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer. | Geburtshilfe Frauenheilkd | 2020 | 33173239 | PubTator, text mining | PubMed |
| Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant. | Cold Spring Harb Mol Case Stud | 2020 | 33172906 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. | Cells | 2020 | 33167477 | PubTator, text mining | PubMed |
| Ganglioside Monosialic Acid Alleviates Peripheral Neuropathy Induced by Utidelone Plus Capecitabine in Metastatic Breast Cancer From a Phase III Clinical Trial. | Front Oncol | 2020 | 33163394 | PubTator, text mining | PubMed |
| 3-O-sulfated heparan sulfate interactors target synaptic adhesion molecules from neonatal mouse brain and inhibit neural activity and synaptogenesis in vitro. | Sci Rep | 2020 | 33154448 | PubTator, text mining | PubMed |
| Combinatorial Therapy of High Dose Vitamin C and PARP Inhibitors in DNA Repair Deficiency: A Series of 8 Patients. | Integr Cancer Ther | 2020 | 33150793 | PubTator, text mining | PubMed |
| Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications? | Stem Cell Rev Rep | 2020 | 33145673 | PubTator, text mining | PubMed |
| Modeling cancer progression using human pluripotent stem cell-derived cells and organoids. | Stem Cell Res | 2020 | 33137568 | PubTator, text mining | PubMed |
| Synthetic Lethality through the Lens of Medicinal Chemistry. | J Med Chem | 2020 | 33135887 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=51